Sunways Rohto Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 6.00 M
as on 16-11-2024
- Paid Up Capital ₹ 3.25 M
as on 16-11-2024
- Company Age 38 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 40.52 Cr
as on 16-11-2024
- Satisfied Charges ₹ 4.28 Cr
as on 16-11-2024
- Revenue -7.18%
(FY 2023)
- Profit 41.95%
(FY 2023)
- Ebitda 100.82%
(FY 2023)
- Net Worth 3.50%
(FY 2023)
- Total Assets 4.55%
(FY 2023)
About Sunways Rohto Pharmaceutical
The Corporate was formerly known as Deep Care Health Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.00 M and a paid-up capital of Rs 3.25 M.
The company currently has active open charges totaling ₹40.52 Cr. The company has closed loans amounting to ₹4.28 Cr, as per Ministry of Corporate Affairs (MCA) records.
Bhadresh Shroff, Sumit Gupta, Daiki Kato, and One other member serve as directors at the Company.
- CIN/LLPIN
U24231GJ1986PTC008689
- Company No.
008689
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 May 1986
- Date of AGM
26 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- LocationAhmedabad, Gujarat
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Sunways Rohto Pharmaceutical?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhadresh Shroff  | Managing Director | 20-Mar-1992 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sumit Gupta | Additional Director | 16-Mar-2023 | Current |
| Anupam Shroff | Director | 16-Oct-2017 | Current |
Daiki Kato  | Additional Director | 15-Jul-2020 | Current |
Financial Performance and Corporate Structure Insights of Sunways Rohto Pharmaceutical.
Sunways Rohto Pharmaceutical Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 7.18% decrease. The company also saw a substantial improvement in profitability, with a 41.95% increase in profit. The company's net worth moved up by a moderate rise of 3.5%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sunways Rohto Pharmaceutical?
In 2023, Sunways Rohto Pharmaceutical had a promoter holding of 75.40% and a public holding of 24.60%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 30 May 2023 | ₹40.50 Cr | Open |
Bank Of India Creation Date: 26 Apr 1988 | ₹0.20 M | Open |
Others Creation Date: 15 Mar 2022 | ₹1.00 Cr | Satisfied |
How Many Employees Work at Sunways Rohto Pharmaceutical?
Sunways Rohto Pharmaceutical has a workforce of 87 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sunways Rohto Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sunways Rohto Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
